Genetic deletion of the long isoform of the von Hippel-Lindau tumour suppressor gene product alters microtubule dynamics

European Journal of Cancer

Volumn 49, Issue 10, 2013, Pages 2433-2440

  Frew, Ian J ^a,b   Smole, Zlatko ^a   Thoma, Claudio R ^a   Krek, Wilhelm ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Microtubules; Mutant mouse; Tumour suppressor; VHL

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEUCINE; METHIONINE; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE DELETION; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; TRANSLATION INITIATION; TRANSLATIONAL INITIATION SITE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; EMBRYO, MAMMALIAN; FEMALE; FIBROBLASTS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MICROTUBULES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY, NUCLEIC ACID; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84878382943     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.02.024     Document Type: Article

References (32)

1. E.R. Maher, H.P. Neumann, and S. Richard Von Hippel-Lindau disease: a clinical and scientific review Eur J Hum Genet 19 6 2011 617 623 [Research Support, Non-U.S. Gov't Review]
2. E.R. Maher Genomics and epigenomics of renal cell carcinoma Semin Cancer Biol 23 1 2012 10 17
3. C. Blankenship, J.G. Naglich, J.M. Whaley, B. Seizinger, and N. Kley Alternate choice of initiation codon produces a biologically active product of the von Hippel-Lindau gene with tumor suppressor activity Oncogene 18 8 1999 1529 1535
4. O. Iliopoulos, M. Ohh, and W.G. Kaelin Jr. PVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation Proc Natl Acad Sci U S A 95 20 1998 11661 11666
5. J. Lisztwan, G. Imbert, C. Wirbelauer, M. Gstaiger, and W. Krek The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity Genes Dev 13 14 1999 1822 1833
6. P.H. Maxwell, M.S. Wiesener, and G.W. Chang The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 6733 1999 271 275
7. H. Yang, Y.A. Minamishima, and Q. Yan PVHL Acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2 Mol Cell 28 1 2007 15 27
8. C.R. Thoma, A. Toso, and K.L. Gutbrodt VHL loss causes spindle misorientation and chromosome instability Nat Cell Biol 11 8 2009 994 1001
9. C.R. Thoma, A. Matov, and K.L. Gutbrodt Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability J Cell Biol 190 6 2010 991 1003
10. M.P. Lolkema, M.L. Gervais, and C.M. Snijckers Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain J Biol Chem 280 23 2005 22205 22211 [Research Support, Non-U.S. Gov't]
11. A. Hergovich, J. Lisztwan, R. Barry, P. Ballschmieter, and W. Krek Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL Nat Cell Biol 5 1 2003 64 70
12. A. Hergovich, J. Lisztwan, C.R. Thoma, C. Wirbelauer, R.E. Barry, and W. Krek Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3 Mol Cell Biol 26 15 2006 5784 5796
13. I.J. Frew, C.R. Thoma, and S. Georgiev PVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation EMBO J 27 12 2008 1747 1757
14. V.H. Haase, J.N. Glickman, M. Socolovsky, and R. Jaenisch Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor Proc Natl Acad Sci U S A 98 4 2001 1583 1588
15. I.J. Frew, R.A. Dickins, and A.R. Cuddihy Normal p53 function in primary cells deficient for Siah genes Mol Cell Biol 22 23 2002 8155 8164
16. M. Ohh, R.L. Yauch, and K.M. Lonergan The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix Mol Cell 1 7 1998 959 968
17. C.R. Thoma, I.J. Frew, C.R. Hoerner, M. Montani, H. Moch, and W. Krek PVHL and GSK3beta are components of a primary cilium-maintenance signalling network Nat Cell Biol 9 5 2007 588 595
18. K.T. Applegate, S. Besson, A. Matov, M.H. Bagonis, K. Jaqaman, and G. Danuser PlusTipTracker: quantitative image analysis software for the measurement of microtubule dynamics J Struct Biol 176 2 2011 168 184 [Research Support, N.I.H., Extramural]
19. J. Gao, J.G. Naglich, J. Laidlaw, J.M. Whaley, B.R. Seizinger, and N. Kley Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene Cancer Res 55 4 1995 743 747 [Research Support, Non-U.S. Gov't]
20. S. O'Gorman, N.A. Dagenais, M. Qian, and Y. Marchuk Protamine-cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells Proc Natl Acad Sci U S A 94 26 1997 14602 14607 [Research Support, U.S. Gov't, P.H.S.]
21. J.R. Gnarra, J.M. Ward, and F.D. Porter Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice Proc Natl Acad Sci U S A 94 17 1997 9102 9107
22. E.B. Rankin, J. Rha, and M.A. Selak Hypoxia-inducible factor 2 regulates hepatic lipid metabolism Mol Cell Biol 29 16 2009 4527 4538 [Research Support, N.I.H., Extramural]
23. E.B. Rankin, J.E. Tomaszewski, and V.H. Haase Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor Cancer Res 66 5 2006 2576 2583
24. 2-regulated prolyl hydroxylation Science 292 5516 2001 468 472
25. 2 sensing and cancer Nat Rev Cancer 8 11 2008 865 873 [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review]
26. E.B. Rankin, D.F. Higgins, J.A. Walisser, R.S. Johnson, C.A. Bradfield, and V.H. Haase Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice Mol Cell Biol 25 8 2005 3163 3172 [Research Support, U.S. Gov't, P.H.S.]
27. S.M. Welford, M.J. Dorie, X. Li, V.H. Haase, and A.J. Giaccia Renal oxygenation suppresses VHL loss-induced senescence that is caused by increased sensitivity to oxidative stress Mol Cell Biol 30 19 2010 4595 4603 [Research Support, N.I.H., Extramural]
28. A.P. Young, S. Schlisio, and Y.A. Minamishima VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400 Nat Cell Biol 10 3 2008 361 369
29. A. Matov, K. Applegate, and P. Kumar Analysis of microtubule dynamic instability using a plus-end growth marker Nat Methods 7 9 2010 761 768 [Research Support, N.I.H., Extramural]
30. A. Dimitrov, M. Quesnoit, S. Moutel, I. Cantaloube, C. Pous, and F. Perez Detection of GTP-tubulin conformation in vivo reveals a role for GTP remnants in microtubule rescues Science 322 5906 2008 1353 1356 [Research Support, Non-U.S. Gov't]
31. D.A. Mans, M.P. Lolkema, M. van Beest, L.G. Daenen, E.E. Voest, and R.H. Giles Mobility of the von Hippel-Lindau tumour suppressor protein is regulated by kinesin-2 Exp Cell Res 314 6 2008 1229 1236
32. B. Schermer, C. Ghenoiu, and M. Bartram The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth J Cell Biol 175 4 2006 547 554